Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of Cardiovascular Autonomic Neuropathy (CAN) on Acute Kidney Injury and Clinical Outcomes in Patients Undergoing Isolated Coronary Artery Bypass Surgery

NCT07254468 is registered in ClinicalTrials.gov with Akdeniz University as lead sponsor.

NCT NCT07254468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07254468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of Cardiovascular Autonomic Neuropathy (CAN) on Acute Kidney Injury and Clinical Outcomes in Patients Undergoing Isolated Coronary Artery Bypass Surgery
Lead sponsor
Akdeniz University
Phase
Observational
Overall status
Completed
Start date
November 4, 2021
Completion date
March 10, 2025
Enrollment
912 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury (aki), cardiovascular autonomic neuropathy (can), coronary artery bypass graft (cabg), postoperative outcomes